Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Open in API
Filings indexed 2,766 across all filing types
Latest filing 2023-01-23 Board/Management Inform…
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content specifically details the departure of a senior executive (Alan M. Lotvin) and the appointment of a new executive (J. David Joyner). This corresponds to changes in the company's board of directors or senior management. The document does not contain financial statements or detailed financial data, but rather announces management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is 4529 characters, which is consistent with a typical 8-K filing for management changes. Confidence is high due to the clear mention of executive departure and appointment under Item 5.02 and Item 7.01 sections of the 8-K.
2023-01-23 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, titled 'Current Report' and dated January 9, 2023. It contains detailed information about the company's reaffirmed full-year 2022 and projected 2023 financial guidance, including adjusted EPS, revenue, operating income, and cash flow from operations. It also discusses share repurchase activity and membership growth metrics. The document includes forward-looking statements and non-GAAP financial measures explanations. The length is over 12,000 characters, indicating substantive content rather than a brief announcement. The content is focused on results of operations and financial condition updates, typical of a current report providing financial results updates outside of regular quarterly or annual reports. This fits the category of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights. It is not a full Annual Report (10-K), Interim Report (IR), or Management Discussion and Analysis (MDA), nor is it a simple announcement or certification. Therefore, the best classification is Earnings Release (ER).
2023-01-09 English
PRIMARY DOCUMENT
Director's Dealing
2023-01-04 English
PRIMARY DOCUMENT
Director's Dealing
2022-12-16 English
PRIMARY DOCUMENT
Director's Dealing
2022-12-02 English
PRIMARY DOCUMENT
Director's Dealing
2022-12-01 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.